Skip to main content
Frontiers in Molecular Neuroscience logoLink to Frontiers in Molecular Neuroscience
. 2022 Jun 9;15:901953. doi: 10.3389/fnmol.2022.901953

Eucommia ulmoides Olive Male Flower Extracts Ameliorate Alzheimer’s Disease-Like Pathology in Zebrafish via Regulating Autophagy, Acetylcholinesterase, and the Dopamine Transporter

Chen Sun 1,2,, Shanshan Zhang 1,2,, Shuaikang Ba 1,2,, Jiao Dang 1,2, Qingyu Ren 1,2, Yongqiang Zhu 1,2, Kechun Liu 1,2, Meng Jin 1,2,*
PMCID: PMC9222337  PMID: 35754707

Abstract

Alzheimer’s disease (AD) is the most prevalent neural disorder. However, the therapeutic agents for AD are limited. Eucommia ulmoides Olive (EUO) is widely used as a traditional Chinese herb to treat various neurodegenerative disorders. Therefore, we investigated whether the extracts of EUO male flower (EUMF) have therapeutic effects against AD. We focused on the flavonoids of EUMF and identified the composition using a targeted HPLC-MS analysis. As a result, 125 flavonoids and flavanols, 32 flavanones, 22 isoflavonoids, 11 chalcones and dihydrochalcones, and 17 anthocyanins were identified. Then, the anti-AD effects of the EUMF were tested by using zebrafish AD model. The behavioral changes were detected by automated video-tracking system. Aβ deposition was assayed by thioflavin S staining. Ache activity and cell apoptosis in zebrafish were tested by, Acetylcholine Assay Kit and TUNEL assay, respectively. The results showed that EUMF significantly rescued the dyskinesia of zebrafish and inhibited Aβ deposition, Ache activity, and occurrence of cell apoptosis in the head of zebrafish induced by AlCl3. We also investigated the mechanism underlying anti-AD effects of EUMF by RT-qPCR and found that EUMF ameliorated AD-like symptoms possibly through inhibiting excessive autophagy and the abnormal expressions of ache and slc6a3 genes. In summary, our findings suggested EUMF can be a therapeutic candidate for AD treatment.

Keywords: AD, AlCl3, Ache, slc6a3, flavonoids

Introduction

Alzheimer’s disease (AD) is a common neurodegenerative disease which is age-related. Patients with AD are characterized by the progressive loss of acquired knowledge and memory decline. The loss of neurons, formation of neurofibrillary tangles, tau protein aggregation, amyloid β-protein (Aβ) deposition, and low levels of acetylcholine (ACh) are the main clinical hallmarks of AD (Kepp, 2016; Sanabria-Castro et al., 2017).

The aging tendency of the population is leading to an increased prevalence of AD. Currently, over 47 million people have been diagnosed with AD, and this has caused heavy burdens for families and society (Neves et al., 2021). To deal with this situation, many AD drugs have been developed, such as anti-tau, an amyloid β-protein (Aβ) aggregation inhibitor, and cholinergic-enhancing and anti-inflammatory drugs. Unfortunately, these drugs are not able to prevent the progression of AD and only can improve cognitive function and memory to a certain extent (Pearson, 2001; Huang and Mucke, 2012). Therefore, the development of AD drugs is an urgent task.

Because of their novel structures and extensive physiological activities, natural products from plants have been always an important source of drug development. Eucommia ulmoides Olive (EUO), also named Du-zhong, is a deciduous tree in the family of Eucommiaceae (Yan et al., 2018). It is also the traditional Chinese herb. The leaf and bark of EUO are officially documented in the Chinese Pharmacopeia. The leaf extracts of EUO are reported to be treat AD, aging, diabetes, hypertension, and osteoporosis (He et al., 2014). However, studies investigating the male flowers of EUO began relatively late. Currently, many studies have shown that the male flowers, like the leaf and bark of EUO, also contain many bioactive components including lignans, megastigmane glycosides, iridoids, phenolics, and flavonoids. These bioactive constituents have typically exhibited neuroprotective, anti-oxidant, anti-tumor, anti-inflammatory, anti-hypertensive, anti-aging, immunity promotion, and other activities (Luo et al., 2010; Kobayashi et al., 2012; Zhang et al., 2012; Niu et al., 2015; Hao et al., 2016; Yan et al., 2018). There are similar bioactive constituents between the male flower and leaf of EUO. Hence, we hypothesize that extracts of the EUO male flower (hereafter referred to as EUMF) may have anti-AD activity.

Zebrafish is an ideal model system for human disease and drug development. They possess a high homology to humans and have rapid development and small sizes (Kerstin et al., 2013; Hong et al., 2020). Many studies have reported that a zebrafish AD model can be established by using AlCl3, an in vivo animal model that can mirror the primary characteristic pathological changes of patients with AD. Various clinical hallmarks of AD can be detected in this model (Huang et al., 2016; Pan et al., 2019). But unfortunately, an important clinical hallmark-Aβ deposition has not yet been successfully detected in zebrafish AD model.

In summary, in this study we isolated and purified the EUMF and identified the chemical compositions. To verify our hypothesis mentioned in the previous paragraph, the zebrafish AD model was used to investigate the therapeutic effect of EUMF on AD symptoms. In addition, Aβ deposition detection was used innovatively in our zebrafish AD model. Finally, we further tested the mRNA expressions of key factors involved in autophagy and the regulation of neurotransmitters to reveal the underlying mechanism.

Materials and Methods

Animals

The adult wild-type zebrafish (AB strain) were maintained in a zebrafish facility at 28.5°C ± 0.5°C with a 14 h light/10 h dark cycle photoperiod at the Key Laboratory for Drug Screening Technology of the Shandong Academy of Sciences. Larvae were obtained from natural mating. Zebrafish larvae at 3 days post-fertilization (dpf) were used this study. All experiments were conducted in compliance with the standard ethical guidelines and under the control of the Biology Institute, the Qilu University of Technology of Animal Ethics Committee.

Preparation of the Eucommia ulmoides Olive Male Flower

The hydrothermal extraction method is used to prepare EUMF. Approximately 20 g of dried EUMF powder was placed into a flask, and 2,000 mL of ultrapure water was added. Then the flask was placed into an electric jacket for extraction by heat reflux three times, 2 h each time. The supernatant was obtained by centrifugation at 5,000 rpm for 10 min. The combined extraction solution was concentrated by rotary evaporation and then freeze-dried to obtain the EUMF.

Identification of Flavonoid Compounds Using HPLC-MS

A targeted HPLC-MS analysis of the flavonoid compounds was performed on SCIEX Qtrap 6500 + system (SCIEX, United States). The Xselect HSS T3 C18 column (2.1 × 150 mm, 2.5 μm) was used for sample separation. Distilled water containing 0.1% formic acid was used as solvent A, and acetonitrile containing 0.1% formic acid was used as solvent B. The elution condition was maintained at 2% B for 2 min, from 2 to 100% B for 13 min, maintained at 100% B for 2 min, and equilibrated with the initial elution solvent for 3 min. The flow rate was 0.4 mL/min. The injection volume of the sample was 1 μL. The column temperature was set to be 50°C. Mass spectrometry was performed in both the positive and negative ion modes. The optimal positive MS parameters were a curtain gas pressure of 35 psig and an ion spray voltage of 5,500 V at a temperature of 550°C. For the negative MS mode, the ion spray voltage was set as −4,500 V and the other parameter was the same as the positive mode. All of the compounds were identified according to LC and MS information and compared with flavonoid compound databases that were supplied by the Novogene Co., Ltd. (Tianjin, China).

Establishment of Zebrafish Alzheimer’s Disease Model

The establishment of the zebrafish AD model referenced to the previous studies (Huang et al., 2016; Pan et al., 2019) with a slight modification. In brief, 3 dpf larval zebrafish were randomly transferred to six-well cell culture plates with a density of approximately 20 larvae per well. Then they were treated with 80 μM AlCl3 from 3 to 6 dpf to generate the zebrafish AD models.

Eucommia ulmoides Olive Male Flower and Donepezil Treatments

The larvae were treated with different concentrations of EUMF (100, 200, 300, 400, 500, 600, 700, 800, and 1,600 μg/mL) from 3 to 6 dpf. We found that the LC1 and LC50 of the EUMF were 206 and 454 μg/mL, respectively, based on the EUMF lethality curve of Figure 1A. LC1 is typically regarded as a no-observed-effect concentration value. Therefore, we tested the anti-AD activity of the EUMF at concentrations below LC1 (206 μg/mL). The zebrafish larvae were co-treated with 80 μM AlCl3 and EUMF at three different concentrations (50, 100, and 200 μg/mL) from 3 to 6 dpf (Figure 1B). Donepezil which is the inhibitor of acetylcholinesterase (Ache) was used as the positive drug. In the positive group, the larvae were co-treated with 80 μM AlCl3 and 4.0 μM donepezil from 3 to 6 dpf. After treatment, 10 larvae from each group were randomly selected for the image acquisition.

FIGURE 1.

FIGURE 1

Mortality curve and experimental workflow chart. (A) Larval zebrafish were exposed to different concentrations of EUMF (100, 200, 300, 400, 500, 600, 700, 800, and 1,600 μg/mL) from 3 to 6 dpf. The mortality was recorded within each group at 3, 4, 5, and 6 dpf. Dead larvae were judged using missing heartbeats. (B) Larvae at 3 dpf were co-exposed to AlCl3 and three different concentrations of EUMF from 3 to 6 dpf. At 6 dpf the zebrafish were subjected to a behavioral test. In addition, we also evaluated the AchE activity, Aβ deposition, and apoptosis in the brain and performed RT-qPCR.

Behavioral Analysis

The larvae from each group were randomly collected, and cleaned using an embryo medium (1 mM MgSO4, 0.5 mM KCl, 15 mM NaCl, 0.05 mM (NH4)3PO4, 0.15 mM KH2PO4, 0.7 mM NaHCO3, and 1 mM CaCl2). They were then placed in 48-well plates. After a 20-min acclimation period, the locomotor activity for each larva was recorded using an automated computerized video-tracking system (Viewpoint, Lyon, France). The behavioral tests contained three alternating light-dark cycles with 60 min (10 min illumination, 10 min darkness alternately). Zeblab software (Viewpoint, Lyon, France) was used to recorded and analyzed the zebrafish movement distance and speed change to light-dark and dark-light cycles.

Detection of the Amyloid β-Protein Deposition

The zebrafish larvae were fixed using 4% paraformaldehyde. All of the fixed zebrafish were processed by embedding in the optimal cutting temperature compound (OCT Compound, SAKURA, United States) and frozen at −20°C until sectioning. Subsequently, the tissue sections were used for thioflavin S staining (Chao et al., 2018). In brief, the sections were washed with 0.01 M phosphate buffered solution (PBS) for 30 min at room temperature. Next, 0.3% thioflavin S (Sigma-Aldrich, Darmstadt, Germany) was introduced, and the sections were incubated for 8 min at room temperature in the dark. Finally, the sections were washed with 0.01 M PBS for 30 min in dark, and a fluorescence microscope (Zeiss, Jena, Germany) was used to analyze the sections. The fluorescence intensity of the Aβ deposition in the head was measured using Image-Pro Plus version 5.1.

Determination of Ache Activity

After co-treatment with AlCl3 and EUMF, zebrafish larvae at 6 dpf were killed by tricaine (Sigma-Aldrich, Darmstadt, Germany). Cold physiological saline was added to the larvae in a 2 mL tube at a ratio of 1:9 (mass:volume) without any additional water. Next, the samples were homogenized using automated tissue homogenization, followed by centrifuged at 2,500 rpm for 10 min at 0°C. The supernatant was collected for the assay. The enzyme activity of Ache was determined by using the Amplite™ Fluorimetric Acetylcholinesterase Assay Kit (AAT Bioquest, California, United States) according to the manufacturer’s instructions with a slight modification as follows. The acetylthiocholine reaction mixture was 50 μM.

The test samples addition added into the acetylthiocholine reaction mixture was also 50 μM. The fluorescence at Ex/Em = 490/520 was monitored.

Apoptosis Assessment

Apoptotic cells in the head were assessed using the One Step TUNEL Apoptosis Assay Kit (Beyotime, Jiangsu, China). Briefly, the zebrafish larvae at 6 dpf were fixed in 4% paraformaldehyde. Next, they were blocked with 3% hydrogen peroxide in methanol and incubated with the TUNEL reaction mixture. The larvae were photographed by using a fluorescence microscope (Zeiss, Jena, Germany). The fluorescence intensities of apoptotic cells in the head were measured using Image-Pro Plus version 5.1.

Detection of Gene Expression

The expression of six genes: autophagy and beclin 1 regulator 1a (ambra1a), autophagy-related gene 5 (atg5), unc-51 like autophagy activating kinase 1 (ulk1b), autophagy-related ubiquitin-like modifier LC3 B (lc3b), acetylcholinesterase (ache), and solute carrier family 6 member 3 (slc6a3) were detected in the zebrafish larvae using RT-qPCR. The total RNA was extracted from the larval tissue using the EASY spin Plus RNA Mini Kit (Aidlab Biotechnologies, Beijing, China) according to manufacturer instructions. Next, RNA was reverse transcribed into cDNA using the PrimeScript™ RT Master Mix (Takara Biomedical Technology Co., Ltd., Beijing, China), The RT-qPCR was conducted using the SYBR® Premix DimerEraser™ (Takara Biomedical Technology Co., Ltd., Beijing, China). The housekeeping gene, rpl13a, was used as a reference gene. The primer sequences of the above genes are shown in Table 1.

TABLE 1.

The sequences of primer pairs used in real-time quantitative PCR assay.

No Gene symbol Forward primer Reverse primer
1 ambra1a TAACCAGGAAACTGGCCAAC AATATGCTGCAGGGGACAAC
2 atg5 AGGGGATAACAGCACAAACG CTTCTTATGCAGCGTGTCCA
3 ulk1b AGGCCGAAAGTCTCACTTCA AGCCATGTACATCGGAGACC
4 lc3b CCTCCAACTCAACTCCAACC GCCGTCTTCGTCTCTTTCC
5 ache TCTTGCCCACTGTGCTACTC TCTTGTACCCTGCACTCTGC
6 slc6a3 CTAATCGCCTTCTCCAGCTACA GGCCACGTTGTGTTTCTGTGACAT
7 rpl13a TCTGGAGGACTGTAAGAGGTATGC AGACGCACAATCTTGAGAGCAG

Statistical Analysis

The data are presented as mean ± SEM. The statistical analyses were conducted using Graph Pad Prism 8.0 (GraphPad Software; San Diego, CA, United States) by a one-way ANOVA followed by the Dunnett’s multiple comparison test. If the P-value was less than 0.05, the difference was considered as significant.

Results

Flavonoids Compounds Analysis of the Eucommia ulmoides Olive Male Flower

A large number of literature studies have shown that flavonoids show neuroprotective effects against AD (Remya et al., 2012; Remya et al., 2014; Bakhtiari et al., 2017; Zhao et al., 2019; Li et al., 2021; Noori et al., 2021; Pragya and Arun, 2021). Thus, the flavonoids were selected as the primary components of EUMF for further study. The total contents of the EUMF flavonoids were determined according to the obtained standard curves of the total flavonoids which was reported in a previous study from our lab (Zhang et al., 2020). According to regression equations (y = 0.0003x + 0.0107), the total contents of the EUMF flavonoids were 45.99 ± 0.5853 mg/g. Moreover, the targeted LC-MS analysis of the flavonoids showed that total 206 compounds were detected (Table 2). Among them, 125 flavonoids and flavanols, 32 flavanones, 22 isoflavonoids, 11 chalcones and dihydrochalcones, and 17 anthocyanins were identified. In addition, quercetin-3′-O-glucoside (relative content of 9.1850%), isoquercitrin (8.8025%), rutin hydrate (8.0753%), rutin (7.9072%), spiraeoside (7.5218%), isotrifoliin (7.3683%), isorhamnetin-3-O-neohespeidoside (6.5757%), naringenin (5.7225%), naringenin chalcone (5.6733%), butin, myricitrin, isomucronulatol-7-O-glucoside, hyperoside, hesperetin 5-O-glucoside, narcissoside, di-O-methylquercetin, lonicerin and morin were the primary components of EUMF. The relative content of these 18 components accounted for greater than 90% of the total flavonoids.

TABLE 2.

Flavonoids compounds identified in EUMF by LC-MS.

No RT (min) Molecular Weight Formula Name Relative content (%) Class
1 0.680 274.084 C15H14O5 Afzelechin 0.0854 Flavonoids
2 0.700 420.454 C25H24O6 Kuwanon A 0.0064 Flavones and Flavanols
3 0.710 448.400 C22H22O11 Methylluteolin C-hexoside 0.0210 Flavones and Flavanols
4 0.720 418.100 C21H22O9 O-methylnaringenin C-pentoside 0.2106 Flavanones
5 0.720 418.394 C21H22O9 Methylnaringenin C-pentoside 0.2024 Flavanones
6 0.730 402.350 C20H18O9 Apigenin C-pentoside 0.0411 Flavones and Flavanols
7 0.730 446.404 C22H22O10 Methylapigenin C-hexoside 0.0837 Flavones and Flavanols
8 0.730 550.460 C25H26O14 di-C, C-pentosyl-luteolin 0.0554 Flavones and Flavanols
9 0.740 478.400 C22H22O12 Selgin C-hexoside 0.0150 Flavones and Flavanols
10 0.780 342.343 C19H18O6 Methylophiopogonanone A 0.0025 Isoflavonoids
11 0.940 478.400 C22H22O12 Selgin 5-O-hexoside 0.0348 Flavones and Flavanols
12 0.950 272.069 C15H12O5 Butein 0.0093 Chalcones and dihydrochalcones
13 0.970 476.430 C23H24O11 Irisolidone 7-O-beta-d-glucoside 0.0106 Isoflavonoids
14 0.970 476.430 C23H24O11 Methylchrysoeriol 5-O-hexoside 0.0136 Flavones and Flavanols
15 0.970 508.430 C23H24O13 Limocitrin O-hexoside 0.0236 Flavones and Flavanols
16 0.980 756.660 C33H40O20 C-hexosyl-apigenin O-hexosyl-O-hexoside 0.0048 Flavones and Flavanols
17 0.980 479.000 C22H23O12 Petunidin 3-O-glucoside 0.0489 Anthocyanins
18 1.000 624.552 C28H32O16 C-hexosyl-chrysoeriol O-hexoside 0.0105 Flavones and Flavanols
19 1.010 286.279 C16H14O5 Sakuranetin 0.0118 Flavanones
20 1.010 416.378 C21H20O9 Methylapigenin C-pentoside 0.0043 Flavones and Flavanols
21 1.040 430.405 C22H22O9 Ononin 0.0468 Isoflavonoids
22 1.130 868.702 C43H32O20 8-Gingerol 0.0069 Flavonoids
23 1.220 576.500 C30H24O12 Procyanidin A1 0.0009 Anthocyanins
24 1.260 576.500 C30H24O12 Procyanidin A2 0.0011 Anthocyanins
25 1.284 254.240 C15H10O4 Chrysin 0.0004 Flavones and Flavanols
26 2.600 332.262 C16H12O8 Laricitrin 0.4216 Flavones and Flavanols
27 4.440 302.279 C16H14O6 Homoeriodictyol 0.0003 Flavanones
28 4.560 302.043 C15H10O7 Tricetin 0.0003 Flavones and Flavanols
29 5.098 306.270 C15H14O7 (-)-epigallocatechin 0.0005 Flavonoids
30 5.210 484.840 C21H21ClO11 Cyanidin 3-O-glucoside 0.0111 Anthocyanins
31 5.213 484.840 C21H21ClO11 Idaein chloride 0.0081 Anthocyanins
32 5.310 466.392 C21H22O12 Taxifolin O-glucoside 0.0064 Flavanones
33 5.380 356.332 C19H16O7 Ophiopogonanone C 0.2663 Flavanones
34 5.390 626.520 C27H30O17 Quercetin-3,4′-O-di-beta-glucopyranoside 0.3593 Flavones and Flavanols
35 5.420 809.120 C33H41O21Cl1 Delphinidin 3-sophoroside-5-rhamnoside 0.0329 Anthocyanins
36 5.442 468.840 C21H21ClO10 Callistephin chloride 0.0005 Anthocyanins
37 5.515 528.890 C23H25ClO12 Malvidin 3-galactoside chloride 0.0005 Anthocyanins
38 5.572 528.890 C23H25ClO12 Oenin chloride 0.0022 Anthocyanins
39 5.602 338.700 C15H11ClO7 Delphinidin chloride 0.0009 Anthocyanins
40 5.680 610.518 C27H30O16 C-hexosyl-luteolin O-hexoside 0.0012 Flavones and Flavanols
41 5.730 594.518 C27H30O15 Apigenin-6,8-di-C-glycoside 0.1253 Flavones and Flavanols
42 5.745 432.380 C21H20O10 Puerarin 0.0031 Isoflavonoids
43 5.810 624.544 C28H32O16 di-C,C-hexosyl-methylluteolin 0.1441 Flavones and Flavanols
44 5.820 594.518 C27H30O15 di-C,C-hexosyl-apigenin 0.2993 Flavones and Flavanols
45 5.890 288.252 C15H12O6 Fustin 0.0043 Flavanones
46 6.030 564.499 C26H28O14 Isoschaftoside 0.0142 Flavones and Flavanols
47 6.040 594.526 C27H30O15 C-pentosyl-chrysoeriol O-hexoside 0.0236 Flavones and Flavanols
48 6.050 564.490 C26H28O14 C-pentosyl-C-hexosyl-apigenin 0.0028 Flavones and Flavanols
49 6.074 564.492 C26H28O14 Schaftoside 0.0828 Flavones and Flavanols
50 6.080 430.628 C27H42O4 Hecogenin 0.0367 Flavonoids
51 6.090 466.398 C21H22O12 Plantagoside 0.0256 Flavanones
52 6.100 448.400 C21H20O11 Luteolin C-hexoside derivative 0.2109 Flavones and Flavanols
53 6.174 448.380 C21H20O11 Isoorientin 0.0972 Flavones and Flavanols
54 6.230 416.378 C21H20O9 Toringin 0.0272 Flavones and Flavanols
55 6.230 446.121 C22H22O10 Sissotrin 0.0007 Isoflavonoids
56 6.250 448.377 C21H20O11 Orientin 0.0972 Flavones and Flavanols
57 6.263 322.700 C15H11ClO6 Cyanidin chloride 0.0007 Anthocyanins
58 6.270 594.518 C27H30O15 Saponarin 0.0360 Flavones and Flavanols
59 6.280 610.525 C27H30O16 Kaempferol-3-gentiobioside 0.0200 Flavones and Flavanols
60 6.280 594.518 C27H30O15 4′-O-Glucosylvitexin 0.0360 Flavones and Flavanols
61 6.300 578.519 C27H30O14 6”-O-xylosyl-glycitin 0.0023 Isoflavonoids
62 6.350 611.500 C27H31O16 Tulipanin 0.3871 Anthocyanins
63 6.360 610.520 C27H30O16.xH2O Rutin hydrate 8.0753 Flavones and Flavanols
64 6.380 596.542 C27H32O15 Neoeriocitrin 0.4294 Flavanones
65 6.390 434.121 C21H22O10 Isohemiphloin 0.0171 Flavanones
66 6.411 578.520 C27H30O14 Vitexin-2-O-rhaMnoside 0.0026 Flavones and Flavanols
67 6.430 612.576 C28H36O15 Neohesperidin dihydrochalcone 0.1784 Chalcones and dihydrochalcones
68 6.430 596.534 C27H32O15 Eriocitrin 0.0007 Flavanones
69 6.451 610.518 C27H30O16 Rutin 7.9072 Flavones and Flavanols
70 6.460 432.113 C21H20O10 Apigenin C-glucoside 0.0009 Flavones and Flavanols
71 6.470 208.255 C15H12O Chalcone 0.5983 Chalcones and dihydrochalcones
72 6.510 594.526 C27H30O15 Kaempferol-3-O-rutinoside 0.0309 Flavones and Flavanols
73 6.530 462.366 C21H18O12 Luteolin-7-O-beta-D-glucuronide 0.0017 Flavones and Flavanols
74 6.530 464.382 C21H20O12 Quercetin-3′-O-glucoside 9.1850 Flavones and Flavanols
75 6.530 464.469 C23H28O10 Isomucronulatol-7-O-glucoside 3.3727 Isoflavonoids
76 6.533 432.378 C21H20O10 Isovitexin 0.0007 Flavones and Flavanols
77 6.540 464.376 C21H20O12 Quercetin-O-glucoside 0.4630 Flavones and Flavanols
78 6.547 464.380 C21H20O12 Myricitrin 4.7113 Flavones and Flavanols
79 6.550 594.159 C27H30O15 Kaempferol 3-O-robinobioside 0.4242 Flavones and Flavanols
80 6.554 464.380 C21H20O12 Hyperoside 2.9062 Flavones and Flavanols
81 6.559 432.380 C21H20O10 Vitexin 0.0006 Flavones and Flavanols
82 6.581 446.404 C22H22O10 Calycosin-7-O-beta-D-glucoside 0.0027 Isoflavonoids
83 6.590 464.419 C22H24O11 Hesperetin 5-O-glucoside 1.6133 Flavanones
84 6.590 464.096 C21H20O12 Spiraeoside 7.5218 Flavones and Flavanols
85 6.590 464.096 C21H20O12 Isotrifoliin 7.3683 Flavones and Flavanols
86 6.590 462.360 C21H18O12 Scutellarin 0.0010 Flavones and Flavanols
87 6.596 464.380 C21H20O12 Isoquercitrin 8.8025 Flavones and Flavanols
88 6.620 448.101 C21H20O11 Trifolin 0.1696 Flavones and Flavanols
89 6.620 448.383 C21H20O11 Luteoloside 0.1774 Flavones and Flavanols
90 6.650 448.377 C21H20O11 Kaempferol7-O-beta-D-glucopyranoside 0.1172 Flavones and Flavanols
91 6.664 448.380 C21H20O11 Luteolin 7-O-glucoside 0.1331 Flavones and Flavanols
92 6.680 432.380 C21H20O10 Apigenin 5-O-glucoside 0.0666 Flavones and Flavanols
93 6.720 462.404 C22H22O11 Chrysoeriol C-hexoside 0.0445 Flavones and Flavanols
94 6.730 594.526 C27H30O15 Lonicerin 1.4742 Flavones and Flavanols
95 6.780 625.560 C28H33O16 Petunidin 3-O-rutinoside 0.0030 Anthocyanins
96 6.780 432.380 C21H20O10 Genistin 0.0018 Isoflavonoids
97 6.790 624.552 C28H32O16 Isorhamnetin-3-O-neohespeidoside 6.5757 Flavones and Flavanols
98 6.825 624.544 C28H32O16 Narcissoside 1.5707 Flavones and Flavanols
99 6.837 580.535 C27H32O14 Narirutin 0.0171 Flavanones
100 6.840 578.520 C27H30O14 Isorhoifolin 0.1097 Flavones and Flavanols
101 6.860 462.410 C22H22O11 Pratensein-7-O-glucoside 0.1006 Isoflavonoids
102 6.864 462.400 C22H22O11 Tectoridin 0.0013 Isoflavonoids
103 6.880 316.262 C16H12O7 Rhamnetin 0.0394 Flavones and Flavanols
104 6.885 304.250 C15H12O7 Taxifolin 0.2520 Flavones and Flavanols
105 6.900 268.269 C16H12O4 Tectochrysin 0.0005 Flavones and Flavanols
106 6.910 306.700 C15H11ClO5 Pelargonidin chloride 0.0008 Anthocyanins
107 6.940 608.545 C28H32O15 Chrysoeriol 7-O-rutinoside 0.0021 Flavones and Flavanols
108 6.940 578.520 C27H30O14 Rhoifolin 0.2416 Flavones and Flavanols
109 6.970 270.241 C15H10O5 6,7,4′-Trihydroxyisoflavone 0.0012 Isoflavonoids
110 6.970 448.383 C21H20O11 Vincetoxicoside B 0.0033 Flavones and Flavanols
111 6.979 580.530 C27H32O14 Naringin 0.0110 Flavanones
112 6.980 418.390 C21H22O9 Liquiritin 0.0054 Flavanones
113 7.010 502.200 C26H30O10 Phellodensin F 0.0034 Flavanones
114 7.020 434.121 C21H22O10 Prunin 0.0868 Flavanones
115 7.038 432.380 C21H20O10 Sophoricoside 0.0075 Isoflavonoids
116 7.060 272.069 C15H12O5 Pinobanksin 0.1659 Flavanones
117 7.080 446.367 C21H18O11 Apigenin7-O-beta-D-glucuronide 0.0006 Flavones and Flavanols
118 7.080 418.351 C20H18O10 Kaempferol 3-A-L-Arabinopyranoside 0.0060 Flavones and Flavanols
119 7.080 432.420 C22H24O9 Heptamethoxyflavone 0.0076 Flavones and Flavanols
120 7.080 434.400 C21H20O10 Resokaempferol 7-O-hexoside 0.0077 Flavones and Flavanols
121 7.120 608.545 C28H32O15 Neodiosmin 0.0006 Flavones and Flavanols
122 7.120 536.000 C24H24O14 Eriodictyol O-malonylhexoside 0.0030 Flavanones
123 7.180 462.404 C22H22O11 Chrysoeriol 5-O-hexoside 0.0047 Flavones and Flavanols
124 7.186 462.403 C22H22O11 Homoplantaginin 0.0058 Flavones and Flavanols
125 7.190 480.376 C21H20O13 Myricetin 3-O-galactoside 0.0185 Flavones and Flavanols
126 7.190 492.430 C23H24O12 Tricin 5-O-hexoside 0.0017 Flavones and Flavanols
127 7.200 610.560 C28H34O15 Neohesperidin 0.0461 Flavanones
128 7.200 448.400 C22H22O11 Chrysoeriol 7-O-hexoside 0.0087 Flavones and Flavanols
129 7.240 448.380 C21H20O11 Quercitrin 0.0074 Flavones and Flavanols
130 7.240 436.410 C21H24O10 Phlorizin 0.0718 Chalcones and dihydrochalcones
131 7.300 476.430 C23H24O11 Methylchrysoeriol C-hexoside 0.0030 Flavones and Flavanols
132 7.320 526.490 C27H26O11 Tricin 4′-O-(beta-guaiacylglyceryl) ether 0.0316 Flavones and Flavanols
133 7.340 318.240 C15H10O8 Myricetin 0.0088 Flavones and Flavanols
134 7.350 432.106 C21H20O10 Kaempferin 0.0009 Flavones and Flavanols
135 7.360 432.106 C21H20O10 Kaempferol 7-O-rhamnoside 0.0007 Flavones and Flavanols
136 7.372 582.550 C27H34O14 Naringin dihydrochalcone 0.0001 Flavanones
137 7.400 688.639 C33H36O16 Tricin 4′-O-(β-guaiacylglyceryl) ether O-hexoside 0.0165 Flavones and Flavanols
138 7.417 286.240 C15H10O6 Fisetin 0.0190 Flavones and Flavanols
139 7.471 418.394 C21H22O9 Isoliquiritin 0.0068 Chalcones and dihydrochalcones
140 7.500 330.289 C17H14O7 Tricin 0.1054 Flavones and Flavanols
141 7.500 578.470 C26H26O15 Tricin O-malonylhexoside 0.0295 Flavones and Flavanols
142 7.510 688.630 C33H36O16 Tricin 4′-O-(beta-guaiacylglyceryl) ether 5-O-hexoside 0.0137 Flavones and Flavanols
143 7.523 436.409 C21H24O10 Trilobatin 0.0356 Chalcones and dihydrochalcones
144 7.575 446.360 C21H18O11 Baicalin 0.0095 Flavones and Flavanols
145 7.635 286.236 C15H10O6 Scutellarein 0.0022 Flavones and Flavanols
146 7.660 314.289 C17H14O6 Kumatakenin 0.0134 Flavones and Flavanols
147 7.660 254.240 C15H10O4 4′,7-Dihydroxyflavone 0.0164 Flavones and Flavanols
148 7.670 534.420 C24H22O14 Tricin 5-O-hexoside derivative 0.0073 Flavones and Flavanols
149 7.790 592.553 C28H32O14 Linarin 0.0019 Flavones and Flavanols
150 7.860 622.571 C29H34O15 Pectolinarin 0.0015 Flavones and Flavanols
151 7.879 594.520 C30H26O13 Tiliroside 0.0020 Flavones and Flavanols
152 7.971 416.000 C21H20O9 Apigenin 4-O-rhamnoside 0.0002 Flavones and Flavanols
153 7.999 288.252 C15H12O6 Eriodictyol 0.3773 Flavanones
154 8.020 286.048 C15H10O6 2′-Hydroxygenistein 0.0155 Isoflavonoids
155 8.049 594.561 C28H34O14 Poncirin 0.0011 Flavanones
156 8.050 302.043 C15H10O7 Morin 1.3804 Flavones and Flavanols
157 8.060 286.240 C15H10O6 Luteolin 0.0010 Flavones and Flavanols
158 8.100 668.600 C33H32O15 Tricin O-sinapoylpentoside 0.0003 Flavones and Flavanols
159 8.180 284.263 C16H12O5 Calycosin 0.0329 Isoflavonoids
160 8.229 314.246 C16H10O7 Wedelolactone 0.0004 Isoflavonoids
161 8.260 460.388 C22H20O11 Wogonoside 0.0027 Flavones and Flavanols
162 8.518 272.253 C15H12O5 Naringenin chalcone 5.6733 Chalcones and dihydrochalcones
163 8.519 500.840 C21H21ClO12 Myrtillin chloride 0.0002 Anthocyanins
164 8.598 274.270 C15H14O5 Phloretin 0.2532 Chalcones and dihydrochalcones
165 8.610 272.069 C15H12O5 Butin 4.9779 Flavanones
166 8.645 270.280 C16H14O4 Echinatin 0.0001 Chalcones and dihydrochalcones
167 8.683 272.250 C15H12O5 Naringenin 5.7225 Flavanones
168 8.700 270.240 C15H10O5 Apigenin 0.0057 Flavones and Flavanols
169 8.720 270.240 C15H10O5 Genistein 0.0002 Isoflavonoids
170 8.800 302.327 C17H18O5 Isomucronulatol 0.0010 Isoflavonoids
171 8.811 286.240 C15H10O6 Kaempferol 0.0106 Flavones and Flavanols
172 8.849 300.263 C16H12O6 Tectorigenin 0.0009 Isoflavonoids
173 8.860 302.079 C16H14O6 7-O-Methyleriodictyol 0.0017 Flavanones
174 8.911 300.260 C16H12O6 Diosmetin 0.0031 Flavones and Flavanols
175 8.960 302.236 C15H10O7 Quercetin 0.0197 Flavones and Flavanols
176 8.969 316.262 C16H12O7 Isorhamnetin 0.0097 Flavones and Flavanols
177 8.972 302.270 C16H14O6 Hesperetin 0.0073 Flavanones
178 9.020 330.074 C17H14O7 3,7-Di-O-methylquercetin 0.0008 Flavones and Flavanols
179 9.160 360.320 C18H16O8 5,7,3′-trihydroxy-6,4′,5′-trimethoxyflavone 0.0000 Flavones and Flavanols
180 9.190 330.100 C17H14O7 Di-O-methylquercetin 1.5690 Flavones and Flavanols
181 9.370 372.375 C20H20O7 Isosinensetin 0.0001 Flavones and Flavanols
182 9.550 372.370 C20H20O7 Sinensetin 0.0002 Flavones and Flavanols
183 9.590 338.360 C20H18O5 Wighteone 0.0004 Isoflavonoids
184 9.594 300.263 C16H12O6 Hydroxygenkwanin 0.6367 Flavones and Flavanols
185 9.870 284.263 C16H12O5 Maackiain 0.0168 Isoflavonoids
186 9.935 300.310 C17H16O5 Farrerol 0.0002 Flavanones
187 10.004 344.320 C18H16O7 Eupatilin 0.0001 Flavones and Flavanols
188 10.110 284.225 C15H8O6 Rhein 0.0004 Anthocyanins
189 10.287 284.260 C16H12O5 Wogonin 0.0014 Flavones and Flavanols
190 10.315 286.279 C16H14O5 Isosakuranetin 0.0023 Flavanones
191 10.340 374.347 C19H18O8 Chrysosplenetin B 0.0001 Flavones and Flavanols
192 10.372 256.250 C15H12O4 Pinocembrin 0.0015 Flavanones
193 10.373 514.520 C27H30O10 Baohuoside I 0.0004 Flavones and Flavanols
194 10.374 374.341 C19H18O8 Casticin 0.0005 Flavones and Flavanols
195 10.400 286.328 C17H18O4 Loureirin A 0.0010 Chalcones and dihydrochalcones
196 10.518 402.390 C21H22O8 Nobiletin 0.0046 Flavones and Flavanols
197 10.520 356.332 C19H16O7 6-Formyl-isoophiopogonanone A 0.0022 Flavanones
198 10.550 284.263 C16H12O5 Oroxylin A 0.0005 Flavones and Flavanols
199 10.780 314.295 C17H14O6 Pectolinarigenin 0.0002 Flavones and Flavanols
200 11.410 372.370 C20H20O7 Tangeretin 0.0030 Flavones and Flavanols
201 11.419 336.720 C16H13ClO6 Peonidin chloride 0.0007 Anthocyanins
202 11.520 388.368 C20H20O8 Demethylnobiletin 0.0001 Flavones and Flavanols
203 11.564 224.250 C15H12O2 Flavanone 0.0007 Flavanones
204 11.740 298.295 C17H14O5 Mosloflavone 0.0009 Flavones and Flavanols
205 11.930 324.370 C20H20O4 Isobavachalcone 0.0005 Chalcones and dihydrochalcones
206 12.143 394.420 C23H22O6 Deguelin 0.0001 Isoflavonoids
207 12.670 368.380 C21H20O6 Anhydroicaritin 0.0000 Flavones and Flavanols

Dyskinesia Rehabilitation Effects of Eucommia ulmoides Olive Male Flower in Zebrafish Larvae

Behavioral tests were performed on the zebrafish larvae at 6 dpf. As shown in Figure 2A, The black lines, green lines, and red lines indicate slow, medium, and fast movements, respectively. We found that the distance traveled by zebrafish in the AD model group was significantly shorter than the zebrafish in the untreated group, whether in light or dark environments (Figure 2B). The speed change of the zebrafish in the AD model group was also notably weakened after light stimulus alteration compared with the zebrafish in the untreated group (Figure 2C). These results indicated that AlCl3 lessened the locomotor capacity of the zebrafish, and this was consistent with the previous study (Pan et al., 2019; Li et al., 2020). Accordingly, the establishment of zebrafish AD model was successful. After treatment with 4.0 μM donepezil, the distance traveled and speed change of the zebrafish both increased compared with the zebrafish in the AD group (Figures 2B,C). This implied that donepezil improved the dyskinesia of zebrafish induced by AlCl3. Interestingly, a similar trend of behavioral change in the positive group was also observed in the EUMF treatment groups. When the zebrafish were co-treated with AlCl3 and different concentrations of the EUMF (50, 100, and 200 μg/mL), their dyskinesias were also reduced. In particular, the EUMF treatment correlated with a longer distance in dark environments than that of the donepezil group (Figures 2B,C). The above results indicated that the EUMF improved the exercise capacity and may play a protective role against AlCl3-induced AD-like symptoms in zebrafish.

FIGURE 2.

FIGURE 2

Effect of EUMF on AlCl3-induced locomotion impairments in zebrafish. (A) Dgital track map. The red, green, and black lines depict fast, medium, and slow movements, respectively (n = 10). (B) Total distance moved in the Ctl, AlCl3, and AlCl3 + EUMF groups (***P < 0.001 vs. Ctl; ###P < 0.001 vs. AlCl3; n = 10). (C) Speed change in the Ctl, AlCl3, and AlCl3 + EUMF groups (the speed change after light stimulus is demarcated by the frame; n = 10).

Inhibition the Amyloid β-Protein Aggregation Effects of Eucommia ulmoides Olive Male Flower in the Zebrafish Larvae

Amyloid β-protein deposition is an important clinical hallmark in AD patients (Meldolesi, 2017). To further identify the anti-AD activity of the EUMF, the Aβ plaques in the heads of zebrafish were quantitatively determined. As shown in Figure 3, only a few of the Aβ plaques were observed in the brain of the untreated group. In contrast, there were many large Aβ plaques in the brain of the AD model group. Compared with the AD group, larval treatment with donepezil or EUMF (50, 100, and 200 μg/mL) significantly reduced the Aβ plaque count. These results implied that EUMF had anti-AD activity.

FIGURE 3.

FIGURE 3

Inhibition of EUMF on Aβ aggregation in zebrafish. (A) The Aβ plaques in the brain region were stained using thioflavin S in the Ctl, AlCl3, and AlCl3 + EUMF groups (Aβ is demarcated by arrows; scale bar = 100 μm). (B) Statistical analysis of the Aβ plaque count in each group (***P < 0.001 vs. Ctl; #P < 0.05; ###P < 0.001 vs. AlCl3; n = 10).

Inhibitory Activity of Eucommia ulmoides Olive Male Flower on the Ache Activity

Ache is an enzyme that can degrade ACh. Many studies have proposed that a reduced level of ACh may be the primary etiology of AD. Hence, Ache has also been proposed to be related to the formation of AD (Remya et al., 2013; Hu et al., 2019). Based on this, we assessed the activity of Ache to explore the protective mechanism of EUMF on AD. As shown in Figure 4, the AD model group showed a higher activity of Ache compared with the untreated group. However, the groups co-treated with both AlCl3 and donepezil or different concentrations of EUMF showed reduced activity of Ache compared with the AD model group. Our results indicated that the EUMF may be an effective therapeutic agent for AD by suppressing the activity of Ache.

FIGURE 4.

FIGURE 4

Inhibition of EUMF on the AChE activity in zebrafish (***P < 0.001 vs. Ctl; #P < 0.05, ##P < 0.01, ###P < 0.001 vs. AlCl3; n = 10).

Effect of Eucommia ulmoides Olive Male Flower on AlCl3-Induced Apoptosis in the Brain

We found many apoptotic cells that appeared primarily in the brain region in the zebrafish AD model. In contrast, no obvious apoptotic cells were observed in the control group. Donepezil or different concentrations of the EUMF treatment significantly reduced the number of apoptotic cells in the zebrafish brains (Figure 5). The above results suggested that EUMF suppressed the apoptosis induced by AlCl3 in zebrafish brain.

FIGURE 5.

FIGURE 5

Effect of EUMF on apoptosis in the brains of the AlCl3-modeled zebrafish. (A) The apoptotic cells were stained with TUNEL (scale bar = 100 μm). (B) Statistical analysis of the apoptotic cells count in the larvae heads (***P < 0.001 vs. Ctl; ###P < 0.001 vs. AlCl3; n = 10).

Effect of Eucommia ulmoides Olive Male Flower on the Expression of Autophagy-Related and Neurotransmitter-Related Genes

Many lines of evidence have suggested that dysregulated autophagy is implicated in a pathogenic role in the neurological diseases (Sheng et al., 2010; Chu, 2018). Therefore, we assayed the expression of autophagy-related genes to investigate whether EUMF protected against AD-like symptoms by regulating autophagy. Ambra1a, atg5, ulk1b, and lc3b are core members involved in autophagy (Kang et al., 2011; Jiang et al., 2013). We found that transcript levels of aforementioned genes were significantly upregulated in the AD model group compared with the control, while when the EUMF reached a certain concentration, it reversed the increases (Figure 6). In addition, we also found that the EUMF treatment under a certain concentration downregulated the expression level of ache and slc6a3, and these were drastically increased after treatment with AlCl3 (Figure 6).

FIGURE 6.

FIGURE 6

Transcriptional alterations of genes. The amount of gene expression was exhibited as the relative expression (shown as fold) compared with the Ctl. (**P < 0.01, ***P < 0.001 vs. Ctl; #P < 0.05, ###P < 0.001 vs. AlCl3). (A–D) Expressions of genes involved in autophagy. (E) Transcript levels of ache. (F) Transcript levels of slc6a3.

Discussion

Alzheimer’s disease is the most common clinical degenerative disease associated with aging. The complex pathogenetic factors of AD have limited its effective treatment. EUO is a traditional Chinese medicine. It has been reported that the extracts of EUO leaf can be used to treat AD. Therefore, we investigated the therapeutic effects of its male flowers on AD like symptoms using zebrafish. We found that the dyskinesia in the zebrafish AD model was significantly improved by EUMF. The Aβ plaques count, Ache activity, and number of apoptotic cells in the zebrafish AD model were also clearly reduced by EUMF. The above results indicated that the EUMF may be an agent for AD treatment. In addition, mechanism investigation revealed that the anti-AD activity of the EUMF may be related to its inhibition of excessive autophagy and abnormal expressions of ache and slc6a3 genes.

Autophagy is an important biological process by which cellular material is degraded by lysosomes or vacuoles and recycled. Paradoxically, it has the characteristics of a double-edged sword. Autophagy can serve to protect the nervous system by clearing degrading damaged organelles or accumulated misfolded proteins in neurons, but it may also induce neuron death and damage the nervous system (Shintani and Klionsky, 2004). Previous studies have shown that autophagy influences the secretion of Aβ to the extracellular space in neurons through either excretory or exocytic mechanisms, and hence it plays a critical role in Aβ plaque formation. Furthermore, extracellular Aβ plaques accumulation is an important pathogenic factor leading to AD (Nilsson et al., 2015). Based on these facts, we hypothesized that AlCl3 may activate abnormal excessive autophagy by upregulating the expression of ambra1a, atg5, ulk1b, and lc3b in zebrafish. Then further damage, referring to the deposition of extracellular Aβ plaques induced by abnormal excessive autophagy, would occur. Finally, AD-like symptoms in the zebrafish were induced. However, EUMF restored high expressions of ambra1a, atg5, ulk1b, and lc3b induced by AlCl3. Thus, autophagy was not excessively activated. Accordingly, this reduced the extracellular Aβ plaque count and reversed AD’s disease-like pathology in zebrafish.

Ache is the gene that encode Ache that inactivates the neurotransmitter ACh by catalyzing its hydrolysis to choline and acetic acid (Hu et al., 2019). Slc6a3 is the gene that encode the dopamine transporter (Dat) that can provide rapid clearance of dopamine (DA) (Dedic et al., 2018). The primary function of ACh is to complete the transmission of neural signals. Once the synthesis and decomposition of ACh is abnormal, neural signaling transition may be blocked. To some extent, AD will be the result (Hu et al., 2019). DA is also a neurotransmitter that is critically implicated in cognitive function. Previous studies have found that the restoration of DA transmission plays a role in learning and memory in the mouse model of AD. DA dysfunction has a pathogenic role in the cognitive decline symptoms of AD (Martorana and Koch, 2014). Because Ache and Dat are inhibitors of ACh and DA, respectively, it is conceivable that they also play a critical role in the occurrence of AD. Interestingly, our results showed that both the expressions of ache and slc6a3 genes were upregulated in the AD zebrafish model. However, treatment with EUMF reduced these increased expressions. Collectively, we suggest that beside of inhibiting the abnormal excessive autophagy, EUMF also reverse AD-like pathology in zebrafish by regulating the expressions of ache and slc6a3 at the transcript levels. Definitely, we will perform gene expression test of other neurotransmitters including glutamate in the future to further investigate the underlying mechanism.

Flavonoids are a group of plant metabolites which can improve the cognitive functions. They can work within the processes associated with AD (Kaur et al., 2022; Maccioni et al., 2022). For example, quercetin belonging to the subcategory of flavonoids can significantly mitigate memory deficits in scopolamine mice model via protection against neuroinflammation and neurodegeneration (Olayinka et al., 2022). Eriodictyol which is a natural flavonoid compound can ameliorate cognitive dysfunction in APP/PS1 mice by inhibiting ferroptosis (Li L. et al., 2022). Anthocyanins can reduce the neuronal damage in in vivo and in vitro models of AD (Li H. et al., 2022). Here, we identified many flavonoids including quercetin-3′-O-glucoside, isoquercitrin, rutin hydrate, rutin, spiraeoside, isotrifoliin, isorhamnetin-3′-O-neohespeidoside, naringenin, naringenin chalcone, butin, myricitrin, isomucronulatol-7-O-glucoside, hyperoside, hesperetin 5-O-glucoside, narcissoside, di-O-methylquercetin, lonicerin, and morin in EUMF. Therefore, flavonoids in EUMF may contribute to its anti-AD effects. However, one limitation of this study is that the exact compounds of flavonoids in EUMF, which act as a promising agent against AD need further investigation. In the further work, we will analyze the composition and activity of the flavonoid compounds in EUMF to thoroughly understand the anti-AD activity of EUMF.

Conclusion

In conclusion, our study provided evidence that EUMF had anti-AD activity. EUMF ameliorated AD-like pathology in zebrafish possibly by inhibiting excessive autophagy and the abnormal expressions of ache and slc6a3. Flavonoid compounds in the EUMF may contribute to this biological process (Figure 7). Our data implied that EUMF is an attractive therapeutic candidate for AD.

FIGURE 7.

FIGURE 7

The proposed mechanism underlying the anti-AD effect of EUMF. EUMF inhibits the excessive autophagy and abnormal expressions of the ache and slc6a3 genes to exert the therapeutic effects against AD-like symptoms. Flavonoids in EUMF may contribute to this biological process.

Data Availability Statement

The original contributions presented in the study are included in the article/supplementary material, further inquiries can be directed to the corresponding author.

Ethics Statement

The animal study was reviewed and approved by the Animal Ethics Committe of Biology Institute, Shandong Academy of Sciences.

Author Contributions

MJ conceptualized the idea and supervised the entire study. CS, SZ, SB, and JD performed the study and analyzed the results. MJ, QR, and YZ analyzed the results. CS and SZ wrote the manuscript. MJ and KL revised the manuscript and contributed to the final form. All authors read and approved the final manuscript.

Conflict of Interest

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Publisher’s Note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

Funding

This work was supported by the Belt and Road Innovative Foreign Experts Project (No. DL2021023004L), the National Natural Science Foundation of China (No. 42006090), and the Jinan Talent Project for Universities (Nos. 2021GXRC106, 2021GXRC111, and 2020GXRC031). We are also grateful for grants from Shandong High-end Foreign Experts Recruitment Program (Nos. WST2019006 and WST2020008), Key R&D Project of Shandong Province (No. 2021CXGC010507), and Science, Education, and Industry Integration Innovation Pilot Project of Qilu University of Technology (Shandong Academy of Sciences) (No. 2020KJC-ZD10).

References

  1. Bakhtiari M., Panahi Y., Ameli J., Darvishi B. (2017). Protective effects of flavonoids against Alzheimer’s disease-related neural dysfunctions. Biomed. Pharmacother. 93 218–229. 10.1016/j.biopha.2017.06.010 [DOI] [PubMed] [Google Scholar]
  2. Chao F., Jiang L., Zhang Y., Zhou C., Zhang L., Tang J., et al. (2018). Stereological investigation of the effects of treadmill running exercise on the hippocampal neurons in middle-aged APP/PS1 transgenic mice. J. Alzheimers Dis. 63 689–703. 10.3233/JAD-171017 [DOI] [PubMed] [Google Scholar]
  3. Chu C. T. (2018). Autophagy in neurological diseases: an update. Neurobiol. Dis. 122 1–2. 10.1016/j.nbd.2018.10.010 [DOI] [PubMed] [Google Scholar]
  4. Dedic N., Kühne C., Jakovcevski M., Hartmann J., Genewsky A. J., Gomes K. S., et al. (2018). Deussing, chronic CRH depletion from GABAergic, long-range projection neurons in the extended amygdala reduces dopamine release and increases anxiety. Nat. Neurosci. 21 803–807. 10.1038/s41593-018-0151-z [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Hao S., Xiao Y., Lin Y., Mo Z. T., Chen Y. X., Peng F., et al. (2016). Chlorogenic acid-enriched extract from Eucommia ulmoides leaves inhibits hepatic lipid accumulation through regulation of cholesterol metabolism in HepG2 cells. Pharm. Biol. 54 251–259. 10.3109/13880209.2015.1029054 [DOI] [PubMed] [Google Scholar]
  6. He X., Wang J., Li M., Hao D., Yang Y., Zhang C. R., et al. (2014). Eucommia ulmoides Oliv.: ethnopharmacology, phytochemistry and pharmacology of an important traditional Chinese medicine. J. Ethnopharmacol. 151 78–92. 10.1016/j.jep.2013.11.023 [DOI] [PubMed] [Google Scholar]
  7. Hong Y., Yu L., Tingting L., Lee H. J., Fang L., Wang Y., et al. (2020). A map of cis-regulatory elements and 3D genome structures in zebrafish. Nature 588 337–343. 10.1038/s41586-020-2962-9 [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Hu Y. H., Yang J., Zhang Y., Liu K. C., Liu T., Sun J., et al. (2019). Synthesis and biological evaluation of 3–(4-aminophenyl)-coumarin derivatives as potential anti-Alzheimer’s disease agents. J. Enzyme Inhib. Med. Chem. 34 1083–1092. 10.1080/14756366.2019.1615484 [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Huang W., Li C., Shen Z., Zhu X., Xia B., Li C. (2016). Development of a zebrafish model for rapid drug screening against Alzheimer’s disease. J. Pharm. Pharmacol. 4 174–185. 10.17265/2328-2150/2016.04.003 30171591 [DOI] [Google Scholar]
  10. Huang Y., Mucke L. (2012). Alzheimer mechanisms and therapeutic strategies. Cell 48 1204–1222. 10.1016/j.cell.2012.02.040 [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Jiang T. F., Zhang Y. J., Zhou H. Y., Wang H. M., Tian L. P., Liu J., et al. (2013). Curcumin ameliorates the neurodegenerative pathology in A53T alpha-synuclein cell model of Parkinson’s disease through the downregulation of mTOR/p70S6K signaling and the recovery of macroautophagy. J. Neuroimmune Pharmacol. 8 356–369. 10.1007/s11481-012-9431-7 [DOI] [PubMed] [Google Scholar]
  12. Kang R., Zeh H. J., Lotze M. T., Tang D. (2011). The beclin1 network regulates autophagy and apoptosis. Cell Death Differ. 18 571–580. 10.1038/cdd.2010.191 [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Kaur R., Sood A., Lang D. K., Bhatia S., Al-Harrasi A., Aleya L., et al. (2022). Potential of favonoids as anti-Alzheimer’s agents: bench to bedside. Environ. Sci. Pollut. Res. 29 26063–26077. 10.1007/s11356-021-18165-z [DOI] [PubMed] [Google Scholar]
  14. Kepp K. P. (2016). Alzheimer’s disease due to loss of function: a new synthesis of the available data. Prog. Neurobiol. 143 36–60. 10.1016/j.pneurobio.2016.06.004 [DOI] [PubMed] [Google Scholar]
  15. Kerstin H., Matthew D. C., Carlos T., Torrance J., Berthelot C., Muffato M., et al. (2013). The zebrafish reference genome sequence and its relationship to the human genome. Nature 496 498–503. 10.1038/nature12111 [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Kobayashi Y., Hiroi T., Araki M., Hirokawa T., Miyazawa M., Aoki N., et al. (2012). Facilitative effects of Eucommia ulmoides on fatty acid oxidation in hypertriglyceridaemic rats. J. Sci. Food Agric. 92 358–365. 10.1002/jsfa.4586 [DOI] [PubMed] [Google Scholar]
  17. Li H., Zheng T. T., Lian F. Z., Xu T., Yin W. Y., Jiang Y. G. (2022). Anthocyanin-rich blueberry extracts and anthocyanin metabolite protocatechuic acid promote autophagy-lysosomal pathway and alleviate neurons damage in in vivo and in vitro models of Alzheimer’s disease. Nutrition 93:111473. 10.1016/j.nut.2021.111473 [DOI] [PubMed] [Google Scholar]
  18. Li L., Li W. J., Zheng X. R., Liu Q. L., Du Q., Jie Y., et al. (2022). Eriodictyol ameliorates cognitive dysfunction in APP/PS1 mice by inhibiting ferroptosis via vitamin D receptor-mediated Nrf2 activation. Mol. Med. 28 11–30. 10.1186/s10020-022-00442-3 [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Li Y., Qin J., Cheng Y., Ai Y., Han Z., Li M., et al. (2021). Polysaccharide from Patinopecten yessoensis skirt boosts immune response via modulation of gut microbiota and short-chain fatty acids metabolism in mice. Foods 10:2478. 10.3390/foods10102478 [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Li Y. Q., Chen Y., Fang J. Y., Jiang S. Q., Li P., Li F. (2020). Integrated network pharmacology and zebrafish model to investigate dualeffects components of Cistanche tubulosa for treating both osteoporosis and Alzheimer’s disease. J. Ethnopharmacol. 254:112764. 10.1016/j.jep.2020.112764 [DOI] [PubMed] [Google Scholar]
  21. Luo L. F., Wu W. H., Zhou Y. J., Yan J., Yang G. P., Ouyang D. S. (2010). Antihypertensive effect of Eucommia ulmoides Oliv. extracts in spontaneously hypertensive rats. J. Ethnopharmacol. 129 238–243. 10.1016/j.jep.2010.03.019 [DOI] [PubMed] [Google Scholar]
  22. Maccioni R. B., Calfio C., Gonzalez A., Luttges V. (2022). Novel nutraceutical compounds in Alzheimer prevention. Biomolecules 12 249–264. 10.3390/biom12020249 [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Martorana A., Koch G. (2014). Is dopamine involved in Alzheimer’s disease? Front. Aging Neurosci. 6:252. 10.3389/fnagi.2014.00252 [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Meldolesi J. (2017). Neurotrophin receptors in the pathogenesis, diagnosis and therapy of neurodegenerative diseases. Pharmacol. Res. 121 129–137. 10.1016/j.phrs.2017.04.024 [DOI] [PubMed] [Google Scholar]
  25. Neves S., Macdonald A., Poole M., Dening K. H. (2021). “Participatory co-design: approaches to enable people living with challenging health conditions to participate in design research,” in Perspectives on Design and Digital Communication II. Springer Series in Design and Innovation, Vol. 14 eds Martins N., Brandão D., Moreira da Silva F. (Cham: Springer; ). 10.1177/14713012211065377 [DOI] [Google Scholar]
  26. Nilsson P., Loganathan K., Sekiguchi M., Matsuba Y., Hui K., Tsubuki S., et al. (2015). Aβ secretion and plaque formation depend on autophagy. Cell Rep. 5 61–69. 10.1016/j.celrep.2013.08.04234 [DOI] [PubMed] [Google Scholar]
  27. Niu X. L., Xu D. R., Luo J., Kong L. Y. (2015). Main iridoid glycosides and HPLC/DAD-Q-TOF-MS/MS profile of glycosides from the antioxidant extract of Eucommia ulmoides Oliverse seeds. Indust. Crops Prod. 79 160–169. 10.1016/j.indcrop.2015.11.027 [DOI] [Google Scholar]
  28. Noori T., Dehpour A. R., Sureda A., Sobarzo-Sanchez E., Shirooie S. (2021). Role of natural products for the treatment of Alzheimer’s disease. Eur. J. Pharmacol. 898:173974. 10.1016/j.ejphar.2021.173974 [DOI] [PubMed] [Google Scholar]
  29. Olayinka J., Eduviere A., Adeoluwa O., Fafure A., Adebanjo A., Ozolua R. (2022). Quercetin mitigates memory deficits in scopolamine mice model via protection against neuroinflammation and neurodegeneration. Life Sci. 292:120326. 10.1016/j.lfs.2022.120326 [DOI] [PubMed] [Google Scholar]
  30. Pan H., Zhang J., Wang Y., Cui K., Cao Y., Wang L., et al. (2019). Linarin improves the dyskinesia recovery in Alzheimer’s disease zebrafish by inhibiting the acetylcholinesterase activity. Life Sci. 222 112–116. 10.1016/j.lfs.2019.02.046 [DOI] [PubMed] [Google Scholar]
  31. Pearson V. E. (2001). Galantamine: a new Alzheimer drug with a past life. Ann. Pharmacother. 35 1406–1413. 10.1345/aph.1A092 [DOI] [PubMed] [Google Scholar]
  32. Pragya P., Arun U. (2021). Flavonoid-based nanomedicines in Alzheimer’s disease therapeutics: promises made, a long way to go. ACS Pharmacol. Transl. Sci. 4 74–95. 10.1021/acsptsci.0c00224 [DOI] [PMC free article] [PubMed] [Google Scholar]
  33. Remya C., Dileep K. V., Tintu I., Variyar E. J., Sadasivan C. (2012). Design of potent inhibitors of acetylcholinesterase using morin as the starting compound. Front. Life Sci. 6:107–117. 10.1080/21553769.2013.815137 [DOI] [Google Scholar]
  34. Remya C., Dileep K. V., Tintu I., Variyar E. J., Sadasivan C. (2013). In vitro inhibitory profile of NDGA against AChE and its in silico structural modifications based on ADME profile. J. Mol. Model. 19 1179–1194. 10.1007/s00894-012-1656-0 [DOI] [PubMed] [Google Scholar]
  35. Remya C., Dileep K. V., Tintu I., Variyar E. J., Sadasivan C. (2014). Flavanone glycosides as acetylcholinesterase inhibitors: computational and experimental evidence. Indian J. Pharm. Sci. 76 567–570. [PMC free article] [PubMed] [Google Scholar]
  36. Sanabria-Castro A., Alvarado-Echeverría I., Monge-Bonilla C. (2017). Molecular pathogenesis of Alzheimer’s disease: an update. Ann. Neurosci. 4 46–54. 10.1159/000464422 [DOI] [PMC free article] [PubMed] [Google Scholar]
  37. Sheng R., Zhang L. S., Han R., Liu X. Q., Gao B., Qin Z. H. (2010). Autophagy activation is associated with neuroprotection in a rat model of focal cerebral ischemic preconditioning. Autophagy 6 482–494. 10.4161/auto.6.4.11737 [DOI] [PubMed] [Google Scholar]
  38. Shintani T., Klionsky D. J. (2004). Autophagy in health and disease: a double-edged sword. Science 306 990–995. 10.1126/science.1099993 [DOI] [PMC free article] [PubMed] [Google Scholar]
  39. Yan J. K., Shi X. L., Donkor P. O., Ding L. Q., Qiu F. (2018). Megastigmane glycosides from leaves of Eucommia ulmoides oliver with ACE inhibitory activity. Fitoterapia 116 121–125. 10.1016/j.fitote.2016.12.001 [DOI] [PubMed] [Google Scholar]
  40. Zhang S. S., Yu Z. P., Xia J. Y., Zhang X. M., Liu K. C., Attila S., et al. (2020). Anti-parkinson’s disease activity of phenolic acids from Eucommia ulmoides oliver leaf extracts and their autophagy activation mechanism. Food Funct. 11 1425–1440. 10.1039/c9fo02288k [DOI] [PubMed] [Google Scholar]
  41. Zhang W. P., Fujikawa T., Mizuno K., Ishida T., Ooi K., Hirata T., et al. (2012). Eucommia leaf extract (ELE) prevents OVX-induced osteoporosis and obesity in rats. Am. J. Chin. Med. 40 735–752. 10.1142/S0192415X12500553 [DOI] [PubMed] [Google Scholar]
  42. Zhao S., Zhang L., Yang C., Li Z., Rong S. (2019). Procyanidins and Alzheimer’s disease. Mol. Neurobiol. 56 5556–5567. 10.1007/s12035-019-1469-6 [DOI] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Data Availability Statement

The original contributions presented in the study are included in the article/supplementary material, further inquiries can be directed to the corresponding author.


Articles from Frontiers in Molecular Neuroscience are provided here courtesy of Frontiers Media SA

RESOURCES